Implantica announces landmark RefluxStop® study of 602 patients across 22 European centers, with up to 6.75-year follow-up, published in Nature's Scientific Reports

VADUZ, Liechtenstein, April 21, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of acid reflux - a condition affecting over 1 billion people...